Moreover, the VEGF-A and pro-inflammatory cytokines cause Fas ligand (FasL) expression by tumor endothelial cells that gain the capacity to put CD8+ T cells but not T-reg cells to death (90). This evidence concerns the gene CD8A and neoplasm.